01 1Viatris
01 1EFAVIRENZ USP
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-08-28
Pay. Date : 2013-08-20
DMF Number : 18230
Submission : 2005-03-30
Status : Active
Type : II
20
Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is EFAVIRENZ USP, with a corresponding US DMF Number 18230.
Remarkably, this DMF maintains an Active status since its submission on March 30, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 28, 2013, and payment made on August 20, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
